首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1448218

全球神经设备市场规模、份额、成长分析、按产品、最终用户 - 产业预测，2024-2031 年

Global Neurology Devices Market Size, Share, Growth Analysis, By Product(Neurostimulation Devices, Neurosurgery Devices), By End User(Hospitals, Neurology Clinics) - Industry Forecast 2024-2031

出版日期: 2024年03月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球神经设备市场规模为145.8亿美元，从2023年的157.6亿美元成长到2031年的293亿美元，预测期间（2024-2031年）复合年增长率为8.1%。成长至9,000 万美元。

许多神经系统疾病，包括癫痫、创伤性脑损伤、脊髓损伤、帕金森氏症和阿兹海默症，是旨在识别、预防和治疗这些疾病的神经病学仪器的焦点。神经设备对于改善神经系统疾病患者的治疗结果和生活品质至关重要。该设备的目的是为医疗保健专业人员提供用于诊断和治疗神经系统疾病的尖端设备和技术。这些工具可以帮助支持治疗性介入、识别异常情况并追踪症状的进程。除了促进早期诊断和早期治疗之外，这些技术还增强了患者照护并提供卓越的临床结果。

由于神经系统疾病盛行率的上升和早期诊断需求的增加，市场正在扩大。癫痫和中风的盛行率不断增加，增加了对神经设备的需求。此外，对改善患者治疗效果的有效诊断和治疗方法的需求日益增长。神经设备的昂贵性质和获得监管批准的严格要求进一步阻碍了市场扩张。

此外，由于技术进步和创新医疗设备公司，该行业正在不断发展。作为从业者和研究人员，我们必须不断研究新的医疗设备，因为对改善患者预后并提供准确诊断的先进设备的需求不断增长。政府扩大医疗设备产业的倡议、增加医疗设施建设的资金以及扩大医疗设备领域的研发活动都促进了市场的成长。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Medtronic（US）
Abbott Laboratories（US）
Boston Scientific Corporation（US）
Koninklijke Philips NV（Netherlands）
Siemens Healthineers AG（Germany）
Stryker Corporation（US）
GE Healthcare（US）
Johnson & Johnson（US）
Zimmer Biomet Holdings, Inc.（US）
Nihon Kohden Corporation（Japan）
Hitachi, Ltd.（Japan）
Brainlab AG（Germany）
Elekta AB（Sweden）
LivaNova PLC（UK）
Nevro Corp.（US）
Natus Medical Incorporated（US）
Penumbra, Inc.（US）
Integra LifeSciences Holdings Corporation（US）
Terumo Corporation（Japan）
Neuropace, Inc.（US）

简介目录

Product Code: SQMIG35A2500

Global Neurology Devices Market size was valued at USD 14.58 Billion in 2022 and is poised to grow from USD 15.76 Billion in 2023 to USD 29.39 Billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).

Numerous neurological conditions, including epilepsy, traumatic brain damage, spinal cord injury, Parkinson's disease, and Alzheimer's disease, are the focus of neurology devices, which are designed to identify, prevent, and cure these conditions. In order to improve patient outcomes and the quality of life for individuals with neurological illnesses, the neurology device is essential. The purpose of this gadget is to give medical practitioners cutting-edge instruments and technologies for the diagnosis and treatment of neurological conditions. These tools support therapeutic intervention, help identify anomalies, and track the course of the condition. In addition to facilitating early diagnosis and treatment, these technologies enhance patient care and yield superior clinical results.

The market is expanding as a result of the rising incidence of neurological disorders and the increased demand for early diagnosis. The need for neurological devices is growing due to the increased prevalence of epilepsy and stroke. Furthermore, there is a growing need for efficient diagnostic and therapeutic approaches that improve patient outcomes. The expensive nature of neurological devices and the strict requirements for obtaining regulatory clearances further impede market expansion.

Additionally, the industry is growing due to technological advancements and innovative medical device companies. As a medical practitioner and researcher, you should always be researching new medical devices because there is a growing need for advanced equipment that improve patient outcomes and provide precise diagnoses. The government's initiative to expand the medical device industry, the rise in finances for the construction of healthcare facilities, and the expansion of research and development activities in the medical device sector all contribute to the growth of the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurology Devices Market Beverage Packaging Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurology Devices Market Segmental Analysis

The product, end user, and geographic segments of the worldwide neurology devices market are separated out. The market is divided into product categories, including cerebrospinal fluid devices, neurosurgical devices, neurostimulation devices, and interventional neurology devices. The market is divided into ambulatory care centers, neurology clinics, and hospitals based on the end user. The market is divided into Latin America, Middle East and Africa, Asia Pacific, North America, and Europe.

Drivers of the Global Neurology Devices Market

The need for neurology devices is still being driven by the rising incidence of neurological conditions like epilepsy, Parkinson's disease, and Alzheimer's disease. The World Health Organization (WHO) states that millions of individuals worldwide suffer from neurological illnesses, which calls for cutting-edge treatment and diagnostic options.

Restraints in the Global Neurology Devices Market

The market for neurology devices is subject to stringent regulations, which include gaining permission from regulatory bodies like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). For smaller producers, complying with these laws can be difficult and expensive, which could impede the expansion of the industry.

Market Trends of the Global Neurology Devices Market

Transition to Less Invasive Techniques In the discipline of neurology, there is a discernible shift toward minimally invasive methods. Benefits of minimally invasive procedures include fewer surgical problems, shorter hospital stays, and faster recuperation periods. The need for neurological devices that allow for precise manipulations with less tissue injury is being driven by this trend.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Neurology Devices Market by Product

Market Overview
Neurostimulation Devices
Neurosurgery Devices
Interventional Neurology Devices
Cerebrospinal Fluid Devices
and Others

Global Neurology Devices Market by End User

Market Overview
Hospitals
Neurology Clinics
and Ambulatory Care Centers

Global Neurology Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brainlab AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natus Medical Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuropace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments